Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Cited In for PubMed (Select 15897946)

1.

Systematic calibration of an integrated x-ray and optical tomography system for preclinical radiation research.

Yang Y, Wang KK, Eslami S, Iordachita II, Patterson MS, Wong JW.

Med Phys. 2015 Apr;42(4):1710. doi: 10.1118/1.4914860.

PMID:
25832060
2.

A review of novel optical imaging strategies of the stroke pathology and stem cell therapy in stroke.

Aswendt M, Adamczak J, Tennstaedt A.

Front Cell Neurosci. 2014 Aug 14;8:226. doi: 10.3389/fncel.2014.00226. eCollection 2014. Review.

3.

Fluorescent imaging of cancerous tissues for targeted surgery.

Bu L, Shen B, Cheng Z.

Adv Drug Deliv Rev. 2014 Sep 30;76:21-38. doi: 10.1016/j.addr.2014.07.008. Epub 2014 Jul 24.

PMID:
25064553
4.

Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability.

Kuruppu D, Brownell AL, Shah K, Mahmood U, Tanabe KK.

Cancer Res. 2014 Aug 1;74(15):4111-21. doi: 10.1158/0008-5472.CAN-13-3472. Epub 2014 May 29.

PMID:
24876106
5.

Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Seibold U, Wängler B, Schirrmacher R, Wängler C.

Biomed Res Int. 2014;2014:153741. doi: 10.1155/2014/153741. Epub 2014 Apr 16. Review.

6.

Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.

Thomas R, Park IK, Jeong YY.

Int J Mol Sci. 2013 Jul 31;14(8):15910-30. doi: 10.3390/ijms140815910. Review.

7.

The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells.

Gu C, Liu L, He Y, Jiang J, Yang Z, Wu Q.

Oncol Lett. 2012 Sep;4(3):443-449. Epub 2012 Jun 21.

8.

Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.

Zhu L, Guo N, Li Q, Ma Y, Jacboson O, Lee S, Choi HS, Mansfield JR, Niu G, Chen X.

Theranostics. 2012;2(8):746-56. doi: 10.7150/thno.4762. Epub 2012 Aug 6.

9.

Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts.

Korotcov AV, Ye Y, Chen Y, Zhang F, Huang S, Lin S, Sridhar R, Achilefu S, Wang PC.

Mol Imaging Biol. 2012 Aug;14(4):443-51. doi: 10.1007/s11307-011-0520-4.

10.

Integrin targeting for tumor optical imaging.

Ye Y, Chen X.

Theranostics. 2011;1:102-26.

11.
12.

A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matrices.

Sawada R, Peterson CY, Gonzalez AM, Potenza BM, Mueller B, Coimbra R, Eliceiri BP, Baird A.

Fibrogenesis Tissue Repair. 2011 Feb 17;4:7. doi: 10.1186/1755-1536-4-7.

13.

In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.

Kuchimaru T, Kadonosono T, Tanaka S, Ushiki T, Hiraoka M, Kizaka-Kondoh S.

PLoS One. 2010 Dec 23;5(12):e15736. doi: 10.1371/journal.pone.0015736.

14.

Magnetically labeled mesenchymal stem cells after autologous transplantation into acutely injured liver.

Shi XL, Gu JY, Han B, Xu HY, Fang L, Ding YT.

World J Gastroenterol. 2010 Aug 7;16(29):3674-9.

15.

Stem cell transplantation in brain tumors: a new field for molecular imaging?

Sandu N, Schaller B.

Mol Med. 2010 Sep-Oct;16(9-10):433-7. doi: 10.2119/molmed.2010.00035. Epub 2010 Jun 30. Review.

16.

Imaging of angiogenesis.

Mulder WJ, Griffioen AW.

Angiogenesis. 2010 Jun;13(2):71-4. doi: 10.1007/s10456-010-9178-9. No abstract available.

17.

Optical Imaging of Bacterial Infection Models.

Leevy WM, Serazin N, Smith BD.

Drug Discov Today Dis Models. 2007 Fall;4(3):91-97.

18.

A biological global positioning system: considerations for tracking stem cell behaviors in the whole body.

Li SC, Tachiki LM, Luo J, Dethlefs BA, Chen Z, Loudon WG.

Stem Cell Rev. 2010 Jun;6(2):317-33. doi: 10.1007/s12015-010-9130-9. Review.

19.

Optical and multimodality molecular imaging: insights into atherosclerosis.

Jaffer FA, Libby P, Weissleder R.

Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1017-24. doi: 10.1161/ATVBAHA.108.165530. Epub 2009 Apr 9. Review.

20.

Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.

Hingtgen S, Ren X, Terwilliger E, Classon M, Weissleder R, Shah K.

Mol Cancer Ther. 2008 Nov;7(11):3575-85. doi: 10.1158/1535-7163.MCT-08-0640.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk